Anne Kasmar, M.D., M.Sc.

Anne G. Kasmar, M.D., M.Sc., joined Parexel in June 2023 as Senior Vice President and Global Therapeutic Area Head — Infectious Disease and Vaccines. Anne brings to Parexel more than 15 years of experience in clinical and translational research spanning academia, philanthropy and biotech.
 
In her role at Parexel, Anne leads a global team in the development of new treatments for infectious diseases.

Prior to joining Parexel, Anne was a lead medical director at Genentech in South San Francisco, California. In this role, she oversaw a cross-functional team researching new therapies for graft-versus-host disease and contributed to the clinical development of novel antibiotics. Prior to joining Genentech, she was a program officer at the Bill and Melinda Gates Foundation in Seattle, Washington where she built and managed a multi-million-dollar portfolio of investments in next-generation tuberculosis vaccines. Her experience also includes serving as an instructor of medicine at Harvard Medical School as well as a clinical assistant in medicine at the Massachusetts General Hospital.

To Anne, the field of infectious disease is full of great stories of discovery and adventure. In addition, clinical syndromes in infectious disease often present as mysteries that can be solved, frequently with very good outcomes. While she truly believes in medicine’s ability to cure disease, she is equally inspired by vaccines’ power to prevent illness at both the individual and the population level.

Anne earned her MD from the University of California San Francisco and her MSc, Immunology of Infectious Diseases from the London School of Hygiene and Tropical Medicine.